Unveiling the Knowledge Frontier: A Scientometric Analysis of COPD with Sarcopenia
Jingfeng Zou,Wen Peng
DOI: https://doi.org/10.2147/copd.s448494
2024-03-13
International Journal of COPD
Abstract:Jingfeng Zou, Wen Peng Department of General Practice, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, WuHan, Hubei, People's Republic of China Correspondence: Wen Peng, Department of General Practice, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jie Fang avenue, WuHan, Hubei, 1227, People's Republic of China, Email Objective: Numerous articles and reviews addressing the intersection of Chronic Obstructive Pulmonary Disease (COPD) with sarcopenia have been documented. However, a significant gap exists in the literature concerning scientometric analysis in this field. This study aimed to concentrate on recent research and elucidate emerging research areas through the examination of COPD with sarcopenia. Methods: Articles in the field were systematically retrieved from the Web of Science Core Collections (WoSCC) spanning from 2003 to 2022. The analysis employed scientometric and keyword analyses through specialized software, including VOSviewer, CiteSpace, and Origin. Results: A comprehensive analysis of 758 articles and reviews in the field of COPD with sarcopenia revealed the United States as the leading contributor in terms of publications and overall influence. Maastricht University emerged as the most prolific institution, with Schols Annemie M. W. J. being identified as the most influential scholar in this field. The International Journal of Chronic Obstructive Pulmonary Disease emerged as the most prolific journal. Notably, COPD with sarcopenia exhibits frequent associations with other diseases, underscoring the complexity of the topic and emphasizing the necessity for comprehensive treatment. Mechanistic and diagnostic aspects, particularly computed tomography, are pivotal in this research field. Osteoporosis emerges as a prospective avenue for future research, encompassing both COPD and sarcopenia. Furthermore, nutrition and physical activity are integral components for managing COPD patients with sarcopenia. Conclusion: This study delineates the distribution of fields, the knowledge structure, and the evolution of major research topics related to COPD with sarcopenia. The identification of keyword hotspots enhances the understanding of the occurrence, development, and future study trends associated with the topic. Keywords: chronic obstructive pulmonary disease, COPD, sarcopenia, scientometric analysis, visualization Chronic Obstructive Pulmonary Disease (COPD), a globally pervasive respiratory disease remains the cause of attributable deaths at a rate of 41.9 per 100,000. Over the past three decades, the overall prevalence has increased by 5.9% with a small difference between genders. 1 Factors like smoking, second-hand smoke exposure, genetic, predisposition, and developmental, and social influences contribute to the progression of COPD to an irreversible stage. Diagnosis relies on identified risk factors, symptoms such as cough and sputum, and spirometry results indicating persistent airflow obstruction. 2 Guidelines for COPD management underscore preventive measures (eg, vaccinations, smoking cessation, and avoidance of exposures) and the treatment manageable traits, including dyspnea, exacerbations, and comorbidities, like sarcopenia, osteoporosis, and others. 3,4 Sarcopenia, a frequently discussed concurrent condition with COPD, manifests as a gradual and widespread decline in skeletal muscle in the elderly population, encompassing reduced muscle strength and mass, as well as muscle quality. 5 Introduced into consensus definitions in 2010 and recognized as an independent disease in 2016, sarcopenia lacks a singular diagnostic criterion despite widely acknowledged definitions by the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) and the Asian Working Group for Sarcopenia 2019 (AWGS2019). 6,7 A recent meta-analysis revealed varying sarcopenia the prevalence (10–27%) due to diverse classifications and cut-off thresholds in studies. 8 Typically diagnosed using dual-energy X-ray absorptiometry (DXA) and bioelectrical impedance analysis (BIA), sarcopenia assessment is complemented by computed tomography (CT) for emphysema characterization in COPD. Emerging tools include CT-morphometric measurement for structure-function associations and CT-quantitative analysis of muscle mass and adipose tissue for assessing disease severity and prognosis in COPD with sarcopenia. 9,10 The literature on COPD with sarcopenia encompasses comprehensive reviews, system reviews, and meta-analysis covering relevance, 11,12 mechanisms, 13 prevalence, 14,15 diagnosis and treatment, 16 and even pathogenesis based Chinese traditional m -Abstract Truncated-
respiratory system